摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1E)-1-(2-Methylphenyl)triaz-1-ene | 3693-20-7

中文名称
——
中文别名
——
英文名称
(1E)-1-(2-Methylphenyl)triaz-1-ene
英文别名
1-(aminodiazenyl)-2-methylbenzene
(1E)-1-(2-Methylphenyl)triaz-1-ene化学式
CAS
3693-20-7
化学式
C7H9N3
mdl
——
分子量
135.17
InChiKey
XDAOHSWNTUSNAB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    50.7
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • Inhibitors of checkpoint kinases
    申请人:Arrington Kenneth L.
    公开号:US20070254879A1
    公开(公告)日:2007-11-01
    The instant invention provides for compounds which comprise substituted triazoloquinazolinones that inhibit CHK1 activity. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting CHK1 activity by administering the compound to a patient in need of treatment of cancer.
    本发明提供了包含替代三唑喹唑啉的化合物,这些化合物抑制CHK1活性。本发明还提供了包含这种抑制化合物的组合物,以及通过将该化合物给予需要癌症治疗的患者来抑制CHK1活性的方法。
  • [EN] A CONTINUOUS PROCESS FOR THE SYNTHESIS OF AZO DYES INVOLVING IN-SITU GENERATION OF DIAZONIUM SALTS<br/>[FR] PROCÉDÉ CONTINU POUR LA SYNTHÈSE DE COLORANTS AZOÏQUES IMPLIQUANT LA GÉNÉRATION IN SITU DE SELS DE DIAZONIUM
    申请人:COUNCIL SCIENT IND RES
    公开号:WO2021095059A1
    公开(公告)日:2021-05-20
    The present disclosure provides a continuous process for the synthesis coupled compounds of diazonium salts including azo dyes involving in-situ generation of diazonium salts. It further discloses a set up to carry out the process for the synthesis of coupled compounds of diazonium salts.
    本公开提供了一种连续合成偶联化合物的重要过程,其中包括偶盐和偶染料,涉及原位生成偶盐。它进一步披露了一个用于合成偶盐偶联化合物的程序设置。
  • Cumarinic pigments, process for their preparation and their use
    申请人:Montedison S.p.A.
    公开号:EP0015361A1
    公开(公告)日:1980-09-17
    The present invention concerns a new class of pigments derived from cumarin and, more particularly, of bis- iminocumarinic and bis-cumarinic pigments having the following formula I described herein before. The present invention also includes novel processes for making the cumarinic pigments of the invention. Also, the invention relates to the use of the novel pigments of the invention for the preparation of paints, storing enamels, inks and pastes for the printing of fabrics. Also, included in this invention is the dyeing of plastic materials with the novel cumarinic pigments.
    本发明涉及一类从积雪草中提取的新型颜料,尤其是具有以下式 I 的双亚积雪草苷和双积雪草苷颜料。本发明还包括制造本发明的积雪草苷颜料的新工艺。此外,本发明还涉及本发明新型颜料在制备涂料、贮存搪瓷、油墨和织物印花浆料中的用途。此外,本发明还包括用新型积雪草颜料对塑料材料进行染色。
  • New bestatin-related compounds as immunopotentiator
    申请人:ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI
    公开号:EP0083931A2
    公开(公告)日:1983-07-20
    3-Amino-2-hydroxy-4-phenylbutanoyl-leucyl-asparagines which are related to bestatin in their chemical structure and which are active to enhance the immune response in living animals are now provided.
    3-Amino-2-hydroxy-4-phenylbutanoyl-leucyl-asparagines 与 bestatin 的化学结构有关,具有增强活体动物免疫反应的活性。
  • The novel microorganism strain Chromobacterium violaceum, pharmaceutically active compounds being produced by the strain, a process for preparing the compounds and the use of these compounds as medicaments
    申请人:MICROBIAL CHEMISTRY RESEARCH FOUNDATION
    公开号:EP0096356A2
    公开(公告)日:1983-12-21
    The present invention relates to the novel microorganism strain Chromobacterium violaceum, comDounds of the formula wherein R is hydrogen or the hydroxyl group, being produced by the afore-mentioned strain and their use as medicaments.
    本发明涉及新型微生物菌株 Chromobacterium violaceum、由上述菌株产生的式中 R 为或羟基的化合物及其作为药物的用途。 其中 R 为或羟基,由上述菌株产生并用作药物。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫